Progression of Extrapyramidal Signs in Alzheimer's Disease: Clinical and Neuropathological Correlates

J Alzheimers Dis. 2016;49(4):1085-93. doi: 10.3233/JAD-150244.

Abstract

Background: Extrapyramidal signs (EPS) are frequent in Alzheimer's disease (AD) and core manifestation of related diseases, i.e., dementia with Lewy bodies and Parkinson's disease; furthermore, Lewy bodies and AD-type pathology occur in all three conditions.

Objective: To identify clusters of EPS progression over time and their clinical and neuropathological correlates.

Methods: 3,502 AD patients with longitudinal assessment from the National Alzheimer's Coordinating Center database were included; 394 provided neuropathological data. k-means algorithm was employed to identify clusters of EPS progression and those were compared in terms of cognitive profile, neuropsychiatric features and neuropathological findings.

Results: Three clusters of EPS progression were identified: no/low (n = 1,583), medium (n = 1,259), and high (n = 660) EPS burden. Compared to those with no/low and medium EPS, those with high EPS had greater cognitive and neuropsychiatric impairment, specifically hallucinations. Despite similar AD-pathology across the three clusters, the high EPS cluster had a significantly number of subjects diagnosed with dementia with Lewy bodies.

Conclusions: Cluster analysis of EPS progression over time identified different subgroups of AD patients with distinct clinical and neuropathological features.

Keywords: Alzheimer’s disease; K-means clustering; Lewy bodies; extrapyramidal signs; longitudinal studies.

MeSH terms

  • Aged
  • Algorithms
  • Alzheimer Disease / pathology
  • Alzheimer Disease / physiopathology*
  • Cluster Analysis
  • Databases, Factual
  • Disease Progression
  • Female
  • Follow-Up Studies
  • Humans
  • Longitudinal Studies
  • Male
  • Neuropsychological Tests
  • Severity of Illness Index